November 2024
Exenatide Injection 300mcg/1.2mL (250mcg/mL) and 600mcg/2.4mL (250mcg/mL)
Approved: November 19, 2024 – Amneal Pharmaceuticals LLC
Treatment for: Type 2 Diabetes
Generic for: Byetta
GENERIC DRUG APPROVALS
Published on November 1, 2024
Related News
Benefit Advisors & Employees - Want to know more?
Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com
Clients: Contact your Client Relations Manager
